Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

256.42 -1.58 (-0.61%)
Streaming Delayed Price Updated: 2:41 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Insulet Earnings: What To Look For From PODD
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect. 
Via StockStory
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know. 
Via StockStory
DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should know. 
Via StockStory
ResMed Getting Close To Elite Stock Group Entry
ResMed also boasts a 93 Composite Rating. The best growth stocks often have a 90 or higher Composite as they begin their biggest runs. 
Via Investor's Business Daily
Stock Of The Day: Different Ways To Profit From SoundHound
Shares of SoundHound AI are trading within a range. Some traders will get involved if the stock breaks out or breaks down. 
Via Benzinga
Topics Artificial Intelligence
ResMed Earnings Analysis: Q2 Recap
Via Benzinga
What 5 Analyst Ratings Have To Say About ResMed
Via Benzinga
Should you consider RESMED INC (NYSE:RMD) for quality investing?
RESMED INC (NYSE:RMD) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
Stock Of The Day: Trading The Range In ResMed
If shares of ResMed (RMD) reach support, potential buyers may start to outbid each other. This could force the shares into an uptrend. 
Via Benzinga
What You Missed On Friday
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 
Via Talk Markets
Topics Stocks / Equities
What's going on in today's session: S&P500 movers
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
Via Chartmill
ResMed (NYSE:RMD) Posts Better-Than-Expected Sales In Q4 But Stock Drops
Medical device company ResMed (NYSE:RMD) announced better-than-expected revenue in Q4 CY2024, with sales up 10.3% year on year to $1.28 billion. Its non-GAAP profit of $2.43 per share was 5.2% above... 
Via StockStory
Why Quality-Oriented Investors Should Consider NYSE:RMD.
Exploring RESMED INC (NYSE:RMD)'s quality characteristics. 
Via Chartmill
In today's session, there are S&P500 stocks with remarkable trading volume.
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below. 
Via Chartmill
Top S&P500 movers in Friday's session
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Tech Stocks Rally, S&P 500 Flirts With Records, Gold Extends All-Time Highs: What's Driving Markets Friday?
Major stock indices have completed their recovery following Monday's sharp drop, buoyed by tech stocks rallying on the back of solid earnings and positive macroeconomic data. The S&P 500 index stands... 
Via Benzinga
Topics Stocks
Friday's session: gap up and gap down stock in the S&P500 index
Stay updated with the S&P500 gap up and gap down stocks on Friday. Get a glimpse of the market's movement during today's session. 
Via Chartmill
ResMed: Digital Health Drives Q2 Growth
ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability. 
Via The Motley Fool
ResMed, In A Buy Zone, Stays Flat After Handily Beating Earnings Views
The company easily beat earnings expectations, while sales were narrowly above. 
Via Investor's Business Daily
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
From ResMed Inc.
Via GlobeNewswire
Reasonable Growth, Debt Levels, and a High ROIC Make RESMED INC (NYSE:RMD) Appealing to Quality Investors.
A fundamental analysis of (NYSE:RMD): Why Quality-Oriented Investors Should Consider NYSE:RMD. 
Via Chartmill
Wall Street Remains Flat, Microsoft Eyes Heaviest Drop Since Late 2022, Gold Sets Fresh Records: What's Driving Markets Thursday?
Wall Street is struggling to find risk-on momentum, with major indexes stuck near the flatline at midday as investors assess the latest earnings reports from mega-cap tech stocks and... 
Via Benzinga
This AppLovin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
From ResMed Inc.
Via GlobeNewswire
Earnings Scheduled For January 30, 2025
Via Benzinga
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
Top Stock Reports For UnitedHealth, Costco & IBM
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Inc., Costco Wholesale Corp., and International Business Machines Corp., as well as a micro-cap... 
Via Talk Markets
Topics Stocks / Equities
Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?
Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea. 
Via Investor's Business Daily
This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
ResMed also boasts a superb 96 EPS Rating out of 99, putting it in the top 4% of all companies for recent and long-term profit growth. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.